Analyst Ratings for Context Therapeutics (CNTX)
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/23/2023 | H.C. Wainwright | Emily Bodnar | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.66 (0.60) |
-9.09% | Details |
| 1/24/2022 | ThinkEquity | Ashok Kumar | New Coverage | Buy (N/A) |
10.00 (N/A) |
2.10 (0.60) |
-71.43% | Details |
